ArticlePloS one2025
Trends, levels, and projections of Head and Neck Cancer in China between 2000 and 2021: Findings from the Global Burden of Disease 2021.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Delayed medical care experiences among patients with head and neck cancers: an exploratory study using patient journey mapping.BMC health services research · 2026Article
- Leveraging machine learning for accurate forecasting of pulmonary tuberculosis epidemics in a coastal city in China.Tropical medicine and health · 2026Article
- A low-cost bedside nomogram integrating TSF and pain for predicting severe malnutrition in nasopharyngeal carcinoma: a prospective cohort study.Frontiers in nutrition · 2026Article
- Global burden and cross-country inequalities in head and neck cancer from 1992 to 2021: results from the global burden of disease study.Health economics review · 2025Article
- Exploring the interaction mechanisms of CD46/TREM1 and LC3B/ATG5 in the inflammation-cancer transformation of oral squamous cell carcinoma based on bioinformatics.Frontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Head and neck cancer (HNC), a condition that is both disfiguring and potentially fatal, has become a critical public health challenge. This study seeks to evaluate the trends in HNC burden and predict its future trajectory in China. Utilizing data from the 2021 Global Burden of Disease database, we focused on the incidence, mortality, and disability-adjusted life years related to lip and oral cavity, nasopharyngeal, and laryngeal cancers within the country. We analyzed changes in incidence and mortality rates using the estimated annual percentage change, age-period-cohort (APC) analysis, and decomposition analysis. Additionally, an Autoregressive Integrated Moving Average model was employed to forecast the future burden of HNC. In 2021, China's incidence rates for lip and oral cavity, nasopharyngeal, and laryngeal cancers were higher than those in 40.98%, 98.05%, and 50.73% of countries worldwide, respectively. The burden of HNC increases significantly with age, particularly among men. The APC analysis indicates a rising incidence of HNC among younger adults. Decomposition analysis comparing 2021-2019 highlighted that ASIR and aging were the primary factors influencing the number of cases and deaths. Projections indicate that the burden of HNC in China is expected to continue rising. To combat this growing issue, it is imperative to enhance public health strategies that focus on prevention, early detection, and efficient resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.